Current Edition


Novartis names longtime analyst as top dealmaker amid organizational shakeup

Dive Brief: Novartis on Tuesday named Ronny Gal, a longtime analyst with advisory firm Bernstein, as its chief strategy and growth officer, the latest move …

Continue Reading →

Novartis to consider sale or separation of Sandoz business

Under CEO Vas Narasimhan, Novartis has slimmed down what was a sprawling conglomerate spanning prescription and generic drugs, eye care and consumer healthcare. The drugmaker …

Continue Reading →

Biotech funder Lightstone raises another $375M for life sciences investing

For the past few years, and especially since the coronavirus pandemic put healthcare in the spotlight, investors have flocked to young biotech companies. Their interest …

Continue Reading →

Private equity dives deeper into biotech with nearly $2B Bain fundraise

The last several years have seen private equity grow more entrenched in healthcare. Using data from Pitchbook, Healthcare Dive found private equity deals in the …

Continue Reading →

AHH raises $50 million from Sheares Healthcare

AHH to leverage expertise of leading healthcare executives and investors to transform specialty healthcare in South Asia Asia Healthcare Holdings (AHH), an operating and investment …

Continue Reading →

Napier launches AI/ML powered healthcare assistant

The Napier Assistant will be available to work with any third-party application to empower key users such as doctors and nurses. Leading Singapore-based healthcare software …

Continue Reading →

Wize Pharma signs distribution agreement in China for LO2A

HPGC is a division of Harbin Pharmaceutical Group Co. Ltd., one of China’s largest healthcare companies with 20,000 employees and assets worth $2.9 billion. Wize …

Continue Reading →